1. Home
  2. IMAB vs AZI Comparison

IMAB vs AZI Comparison

Compare IMAB & AZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • AZI
  • Stock Information
  • Founded
  • IMAB 2014
  • AZI 2010
  • Country
  • IMAB United States
  • AZI China
  • Employees
  • IMAB 220
  • AZI N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • AZI
  • Sector
  • IMAB Health Care
  • AZI
  • Exchange
  • IMAB Nasdaq
  • AZI Nasdaq
  • Market Cap
  • IMAB 79.9M
  • AZI 84.9M
  • IPO Year
  • IMAB 2020
  • AZI 2024
  • Fundamental
  • Price
  • IMAB $0.99
  • AZI $0.69
  • Analyst Decision
  • IMAB Strong Buy
  • AZI
  • Analyst Count
  • IMAB 3
  • AZI 0
  • Target Price
  • IMAB $8.00
  • AZI N/A
  • AVG Volume (30 Days)
  • IMAB 274.1K
  • AZI 73.6K
  • Earning Date
  • IMAB 03-13-2025
  • AZI 01-27-2025
  • Dividend Yield
  • IMAB N/A
  • AZI N/A
  • EPS Growth
  • IMAB N/A
  • AZI N/A
  • EPS
  • IMAB N/A
  • AZI N/A
  • Revenue
  • IMAB $3,313,984.00
  • AZI $124,737,000.00
  • Revenue This Year
  • IMAB N/A
  • AZI N/A
  • Revenue Next Year
  • IMAB N/A
  • AZI N/A
  • P/E Ratio
  • IMAB N/A
  • AZI N/A
  • Revenue Growth
  • IMAB N/A
  • AZI 9.86
  • 52 Week Low
  • IMAB $0.84
  • AZI $0.69
  • 52 Week High
  • IMAB $2.08
  • AZI $4.05
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 43.19
  • AZI N/A
  • Support Level
  • IMAB $1.03
  • AZI N/A
  • Resistance Level
  • IMAB $1.10
  • AZI N/A
  • Average True Range (ATR)
  • IMAB 0.06
  • AZI 0.00
  • MACD
  • IMAB -0.01
  • AZI 0.00
  • Stochastic Oscillator
  • IMAB 7.58
  • AZI 0.00

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares

Autozi Internet Technology (Global) Ltd is one of China's leading and fast-growing lifecycle automotive service providers. It provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels nationwide. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.

Share on Social Networks: